Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083198 · ClinicalTrials.gov registry record
Effects of IV Chloride Content on Outcomes
A clinical trial of SIRS and Balanced Fluids, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 1,558
- Enrollment target
- 1
- Study location
NCT02083198: Completed study of SIRS and Balanced Fluids, sponsored by Baxter Healthcare Corporation.
NCT02083198 is a study of SIRS and Balanced Fluids that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 1,558 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02083198, a study of SIRS and Balanced Fluids, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 1,558 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions are associated with adverse outcomes as measured by administrative data and by clinical parameters.
Primary Outcome
Inpatient mortality. Expected Length of inpatient stay is approximately 7 days
Conditions Studied
Study Locations (1)
Illinois
- Baxter Healthcare - Deerfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,558 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-04-01 |
What the finished NCT02083198 record still lists
NCT02083198 is an observational study that tracks outcomes without assigning an intervention. Its 1,558 participants enrollment target places it among the larger protocols in the corpus.
The record links to 3 conditions, with SIRS appearing as the primary indexed condition, and to 0 interventions.
NCT02083198 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02083198 about?
NCT02083198 is a clinical study titled "Effects of IV Chloride Content on Outcomes". This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions ar...
What is the current status of trial NCT02083198?
This trial is currently completed. The enrollment target is 1,558 participants. The study started on 2013-09. Estimated completion is 2014-04-01.
What conditions does trial NCT02083198 study?
This clinical trial studies the following conditions: SIRS, Balanced Fluids, Plasmalyte.
Who is sponsoring clinical trial NCT02083198?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02083198 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SIRS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia